RenovoRx

RNXT40

Penny Stock

$1.090.00%$0.00

Penny Stock

RNXT40

$1.09

0.00%$0.00

Penny Stock

Performance History

Key Stats
Open	$1.11
Prev. Close	$1.09
EPS	-0.60
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$26.14M
PE Ratio	-

	LOW	HIGH
Day Range	1.08	1.14
52 Week Range	0.53	2.35

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-0.60

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About RenovoRx (RNXT)

RenovoRx, Inc. (RNXT) is a medical technology company specializing in the development and commercialization of innovative drug delivery systems. The company's primary focus is on the treatment of solid tumors, with a particular emphasis on pancreatic cancer. RenovoRx's flagship product, the RenovoCath System, is a unique device that enables targeted delivery of therapeutic agents directly to the tumor site. This localized approach offers several advantages over traditional systemic chemotherapy, including increased drug concentration at the tumor site and reduced systemic toxicity.

The RenovoCath System utilizes a dual-balloon catheter to isolate the tumor and create a controlled environment for drug infusion. The device can be navigated within the vasculature using standard endovascular techniques, allowing for precise placement and targeting. Once in position, the RenovoCath System delivers the therapeutic agent through the catheter, directly to the tumor site. This localized delivery approach has shown promising results in early clinical trials, with significant tumor response rates and improved patient outcomes.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. Shaun R. Bagai
Headquarters: Los Altos
Employees: 10
Exchange: NASDAQ

Keep an eye on RenovoRx

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is the 52-week high and low for RenovoRx (RNXT)?

For RenovoRx (RNXT), the 52-week high is $2.35, which is 115.6% from the current price. The 52-week low is $0.53, the current price is 105.27% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

What is RenovoRx's (RNXT) price per share?

The current price per share for RenovoRx (RNXT) is $1.09. The stock has seen a price change of $0 recently, indicating a 0% change. This reflects the stock's recent market performance and investor sentiment.

help

Is RenovoRx (RNXT) a growth stock?

RenovoRx (RNXT) has shown an average price growth of -6.65% over the past three years. It has received a score of 23 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying RenovoRx as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is RenovoRx (RNXT) stock price performance year to date (YTD)?

As of the latest data, RenovoRx (RNXT) has a year-to-date price change of -44.95%. Over the past month, the stock has experienced a price change of 9%. Over the last three months, the change has been 2.83%. Over the past six months, the figure is -20.44%.

help

Is RenovoRx (RNXT) a profitable company?

RenovoRx (RNXT) has a net income of -$10.23M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$11.4M. Furthermore, the EBITDA is $0.

help

What is the market capitalization of RenovoRx (RNXT)?

RenovoRx (RNXT) has a market capitalization of $26.15M. The average daily trading volume is 1.1, indicating the stock's liquidity and investor engagement.